secwatch.observer — SEC 8-K summary
======================================

Issuer:     Onconetix, Inc. (ONCO)
CIK:        0001782107
Form:       8-K/A
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001213900-26-034054
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Onconetix appoints David White CEO, Sammy Dorf to board; Ramdeen resigns
------------------------------------------------------------------------

- David White appointed CEO effective March 18, 2026; monthly base salary of $21,700.
- Timothy Ramdeen resigned from board and committees on March 19, 2026; no disagreement.
- Sammy Dorf appointed to board and audit committee effective March 19, 2026.
- Compensation reductions: Fedasz reduced by $5,000/mo, Oakley reduced by $26,000/mo, effective March 18.
- White's employment agreement includes one-year non-compete and confidentiality covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026034054/0001213900-26-034054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782107/000121390026034054/ea0283337-8ka1_onconetix.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-034054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer